Esperion

Esperion is a leading global biopharmaceutical company focused on developing innovative treatments for cardiovascular disease. Through commercial execution and international partnerships, it aims to provide broad access to its approved therapies. With a commitment to advancing its pre-clinical pipeline, Esperion is pioneering research in ACLY biology and developing next-generation inhibitors to address pressing health challenges.